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Editorials 
The LDSO- The Beginning of the End 
Andrew N. Rowan 
The Basis of the Argument 
Measurement is very important in 
science. Early lessons in the science class-
room involve teaching students to meas-
ure lengths, volumes, weights, specific 
gravities and anything else within the 
mental and economic compass of the 
teacher. At the same time, the question 
of significance is drummed into the 
students' heads. Thus, if one has a 
meter-rule which is subdivided into cen-
timeters (but not millimeters), one is 
taught that the measurement of its length 
to one decimal point (for example, 10.3 em) 
is acceptable, but that the addition of 
any more figures (for example, 10.325 em) 
is mere braggadocio. The eye can only 
make a rough guess at the subdivision be-
tween the centimeter divisions, and add-
ing more figures after the decimal point 
does not improve the accuracy of the es-
timate. 
However, adding more numbers, with-
out increasing the accuracy of the meas-
urement, is precisely what is being attempt-
ed when the LD50 is used as a measure 
of the acute toxicity of chemicals. (The 
LD50 is the amount of a substance which, 
if administered in a single dose to a target 
group of animals, will kill 50 percent of 
them). Normally, 50 to 200 animals are 
used to estimate the LD50 and provide 
its standard deviation from the mean. 
For some reason, regulators and some 
toxicologists appear to believe that an 
LD50 with its fiducial limits is more ac-
curate and more relevant than a rough 
estimate of the acute toxicity, an estim-
ate that can be obtained by using as few 
4 
as six animals (rather than the 50-200 an-
imals needed for an LD50). 
The point at issue, therefore, is sim-
ply this: Animal welfare groups and many 
toxicologists want to see the LDSO (per-
formed on 50 or more animals) replaced 
within the next year by a rough estimate 
of acute toxicity. The regulatory authori-
ties have so far resisted making the nec-
essary changes. 
History 
In 1927, J.W. Trevan published his 
classic report on toxicity determination, 
in which he asserted that the median lethal 
dose (or LD50), done in a large (50-200) 
sample of animals, provided the most 
accurate index of a chemical's toxicity 
(Proc Roy Acad Soc 101 8:483-514). He 
was, however, concerned mainly with 
the accurate standardization, by biologi-
cal methods, of those drugs that are not 
available in a chemically pure form. For 
example, each new batch of such impor-
tant drugs as digitalis extract, insulin, 
and diphtheria toxin had to be accurate-
ly standardized since the margin of safe-
ty between therapeutic and toxic doses 
is so small. Even today, the U.S. Pharma-
copoeia requires a bioassay standardiza-
tion of powdered digitalis that involves 
comparing the lethal dose in pigeons 
against a reference standard. 
However, the number of LD50 deter-
minations used to standardize potent 
biological therapeutics now represents 
only a small proportion of the LD50 tests 
conducted annually. Most LD50 testing 
is done to provide a figure for the toxicity 
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of other classes of chemicals. But some-
how the LDSO figure has gained a totally 
undeserved position as the toxicological 
reference standard; it seems to be regard-
ed in nearly the same light as such physi-
cal constants as melting point and speci-
fic gravity. But as Trevan and his colleag-
ues recognized, the LDSO of a substance 
is not a fixed value; it varies according to 
many extraneous factors, sometimes by 
substantial amounts (see Tables 1 and 2). 
In the last 15 years, however, the 
use of the LD50 as a toxicological stan-
dard has come in for increasing criticism 
among toxicologists (see Arch Toxicol 47: 
77-99, 1981 ). It is not that they deny the 
need for some sort of rough numerical 
estimate of acute toxicity in a mammal-
ian species. Rather, they deny the utility 
of the precise statistical figure that is 
provided by the usual LD50 test. It is 
most important that this point be clearly 
recognized. The immediate argument 
over the LD50 is not that we do not need 
acute toxicity data, but that we can get 
the kind of data we need from small-scale 
tests in a few animals. We do not need 
to kill as many animals as we do merely 
to provide statistical precision. 
Protest Against the LD50 
In the last decade, animal welfare 
criticism of the LDSO test has become in-
creasingly vocal and sophisticated. In 
England, such criticism prompted a rela-
tively unusual initiative from the Home 
Secretary. In 1977, he asked the Adviso-
ry Committee to the Cruelty to Animals 
Act, 1876, to review the extent of the use 
of the LD50 test, as well as the scientific 
necessity and justification for the test in 
its various applications. The Advisory 
Committee listened to extensive evidence 
from animal welfare critics and the sci-
entific community. Interestingly, the 
scientific and regulatory groups, while 
more restrained in tone, were often just 
as critical of the LD50 test as the animal 
welfare groups. 
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The Association of the British Phar-
maceutical Industry concluded that: 
"estimation of LD50 is not an essential 
requirement to ensure the safety of all 
new drugs. Adequate information regard-
ing the acute toxicity, including the 
acute lethality, of new drugs can often 
be obtained by the use of smaller num-
bers of animals than are conventionally 
used in LD50 determinations." The Chemi-
cal Industries Association proposed that 
(1) regulatory agencies be discouraged 
from demanding precise LD50 figures; 
(2) emphasis be placed on the qualitative 
data obtainable from small-scale acute 
toxicity studies; and (3) no animal should 
be administered a quantity greater than 
5 g (or 5 ml) of a substance per kg of 
body weight (the so-called Limit test). 
The Scottish Home and Health Depart-
ment noted that "there is no case to be 
made for requiring LD50 tests to provide 
a value with small fiducial limits. An ap-
proximate estimate suffices." 
By contrast, the Medical Research 
Council (MRC), after explaining that pre-
cise data on acute toxicity were not real-
ly necessary, concluded that "the LD50 
test is the only reliable measure of acute 
toxicity and yields a result with the least 
possible expenditure of life." However, 
they followed this assertion with a state-
ment that only a simple test, using a small 
number of animals, should be done to 
assess the order of magnitude of a chem-
ical's toxicity. Clearly, when the MRC 
talked of the need for an LD50, they 
really meant that what we need to per-
form in most cases is a small-scale acute 
toxicity test. 
Unfortunately, the MRC was not 
the only group to confuse the notion of 
small-scale acute toxicity testing with 
the LD50 test. When the Home Office re-
port finally appeared in 1979, their first 
recommendation was that "LD50 tests 
should be allowed to continue." Although 
they qualified this recommendation by 
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advising that only a small numbers of 
animals need be used, the harm had been 
done: A government enquiry had found 
that LDSO tests needed to continue. I 
cannot say that I, personally, found the 
Committee's findings particularly sur-
prising. When I gave testimony to the 
Committee (on behalf of FRAME- for 
whom I was working at the time), one of 
the expert advisors was almost plaintive 
in defending the toxicologist's need for a 
baseline figure for acute toxicity (i.e., 
the LDSO) and the other did not appear 
to accept the distinction between small-
scale acute toxicity testing and the full 
LDSO. 
Recent Developments 
Despite the setback presented by 
the 1979 report from the British Home 
Office, there are now some encouraging 
signs that an unlikely alliance of animal 
welfare and industrial organizations 
may prevail upon regulatory bodies and 
effect a revolution in acute toxicity 
testing. For example, if regulatory bodies 
would agree to prohibit the submission 
of LDSO figures except in those few cases 
where scientific justification can be pro-
vided for an LDSO determination, we 
would reduce the number of animals used 
in determining lethal doses by about 
80-90 percent. Numerically, this would 
probably amount to 2-4 million animal 
lives saved every year. What events have 
occurred to change the climate of opin-
ion since 1979? 
First, an international coalition of 
animal welfare groups has been formed 
with the specific aim of abolishing the 
LDSO test. A similar coalition against the 
Draize test was very successful (see lnt j 
Stud Anim Prob 3:94-97), and there is 
every reason to hope for similar success 
if a concerted campaign can be mounted 
over the next year. The immediate goal 
will be to get the regulatory agencies to 
switch from tacit or explicit requirements 
for LDSO data to an explicit prohibition 
6 
Editorial 
on the submission of LDSO data, unless 
accompanied by scientific justification. 
Second, on October 21, 1982, the 
Pharmaceutical Manufacturers Associa-
tion (U.S.) called for a revision of govern-
ment regulations so that fewer animals 
are used in drug safety evaluation. They 
specifically noted that "the classical 
LDSO test which utilizes many animals 
to determine an LDSO value with math-
ematical precision lacks justification ... " 
They proposed that: (1) the precise deter-
mination of an LDSO should be limited 
to those rare cases where it is necessary; 
(2) an approximate lethal dose plus qual-
itative data usually represents adequate 
information on the acute toxicity of drugs; 
and (3) there should be an international 
effort to reach agreement among regula-
tory agencies that, for drugs, a precise 
LDSO determination is not necessary. 
Third, at a number of recent scien-
tific meetings, the overwhelming con-
sensus has been that the LDSO is unnec-
essarily precise- qualitative and semi-
quantitative data from small-scale acute 
toxicity tests is usually adequate. For ex-
ample, at a FRAME conference, pharma-
ceutical company staff in the audience 
voted to abolish the LDSO test by 20 to 1 
(New Scientist, November 4, 1982, p. 275). 
At a conference that specifically address-
ed the LDSO test in Sweden (September, 
1981), a clinical toxicologist from the 
Karolinska Poison Information Center 
stated that the numerical information 
provided by an animal LDSO is virtually 
useless. Other scientific meetings on the 
use of animals in acute toxicity testing 
are planned. The indications are that 
these meetings will confirm the useless-
ness of precise LDSO data. All this activi-
ty on the part of scientists, combined 
with animal welfare protests, should es-
calate the pressure to the point that reg-
ulatory bodies are forced to take action. 
Conclusion 
A reassessment of the need for LDSO 
figures is long overdue. Bureaucrats may 
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not be comfortable with approximate leth-
al dose figures, but there are clearly few 
cases where LDSO determinations amount 
to anything more than pseudoscientific 
nonsense. LDSO testing continues, not be-
cause it receives broad endorsement but 
because nobody feels sufficiently s~cure 
to take the decisive action that is neces-
Editorial 
sary to eradicate 40 years of thoughtless 
tradition. Since death by poisoning cannot 
be particularly pleasant, regulatory agen-
cies that are serious about animal wel-
fare issues ought to begin to take steps 
to abolish unnecessary LDSO testing, es-
pecially since the scientific verdict 
against it is already in. 
TABLE 1 Human Acute lethal Doses and Animal LD50's (Oral) 
Human Animal LD50 
LDLo 
(mg/kg) Rat Mouse Rabbit Dog 
Amytal 43 560 575 
Boric Acid 640 2660 3450 
Caffeine 192 192 620 
Carbofuran 11 5 2 
Lindane 840 125 130 120 
Fenflurazole 238 1600 28 
Cycloheximide 3 133 65 
Compiled from CRC Handbook of Analytical Toxicology and the NIOSH Registry of Toxic Effects of Chem-
Ical Substances 
TABLE 2 Range of LD50 Values for Five Compounds Tested Under Similar 
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